Prevention of Early Asthma in Kids (PEAK)

• Status: Completed
• Trial end date: 2004-09-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma phenotypes, genotypes, and ethnic backgrounds and children at different developmental stages.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Collaborator: Childhood Asthma Research and Education Network
• Treatments: Anti-Asthmatic Agents

Criteria

Asthmatic children from birth to 18 years. Emphasis is placed on infants and young children through 5 years of age.